SK285669B6 - Ekteinascidínová zlúčenina, farmaceutický prostriedok s jej obsahom a jej použitie - Google Patents
Ekteinascidínová zlúčenina, farmaceutický prostriedok s jej obsahom a jej použitie Download PDFInfo
- Publication number
- SK285669B6 SK285669B6 SK1501-2000A SK15012000A SK285669B6 SK 285669 B6 SK285669 B6 SK 285669B6 SK 15012000 A SK15012000 A SK 15012000A SK 285669 B6 SK285669 B6 SK 285669B6
- Authority
- SK
- Slovakia
- Prior art keywords
- mammalian
- ecteinascidin
- iso
- ecteinascidin compound
- fab
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Dental Preparations (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8080298P | 1998-04-06 | 1998-04-06 | |
PCT/US1999/007471 WO1999051238A1 (en) | 1998-04-06 | 1999-04-05 | Semi-synthetic ecteinascidins |
Publications (2)
Publication Number | Publication Date |
---|---|
SK15012000A3 SK15012000A3 (sk) | 2001-08-06 |
SK285669B6 true SK285669B6 (sk) | 2007-06-07 |
Family
ID=22159716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1501-2000A SK285669B6 (sk) | 1998-04-06 | 1999-04-05 | Ekteinascidínová zlúčenina, farmaceutický prostriedok s jej obsahom a jej použitie |
Country Status (28)
Country | Link |
---|---|
US (1) | US6124293A (uk) |
EP (2) | EP1067933B1 (uk) |
JP (1) | JP4443043B2 (uk) |
KR (1) | KR100603219B1 (uk) |
CN (1) | CN1157189C (uk) |
AT (1) | ATE370148T1 (uk) |
AU (1) | AU758100B2 (uk) |
BG (1) | BG65088B1 (uk) |
BR (1) | BR9909488B1 (uk) |
CA (1) | CA2327468C (uk) |
CY (1) | CY1106988T1 (uk) |
CZ (1) | CZ301083B6 (uk) |
DE (1) | DE69936845T2 (uk) |
DK (1) | DK1067933T3 (uk) |
ES (1) | ES2292237T3 (uk) |
HK (1) | HK1033651A1 (uk) |
HU (1) | HUP0104273A3 (uk) |
IL (2) | IL138856A0 (uk) |
MX (1) | MXPA00009840A (uk) |
NO (1) | NO328147B1 (uk) |
NZ (1) | NZ507350A (uk) |
PL (1) | PL196809B1 (uk) |
PT (1) | PT1067933E (uk) |
RU (1) | RU2217432C2 (uk) |
SK (1) | SK285669B6 (uk) |
TR (1) | TR200002921T2 (uk) |
UA (1) | UA59439C2 (uk) |
WO (1) | WO1999051238A1 (uk) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985876A (en) * | 1997-04-15 | 1999-11-16 | Univ Illinois | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
ES2239442T3 (es) * | 1998-05-11 | 2005-09-16 | Pharma Mar, S.A. | Metabolitos de ecteinascidina 743. |
MY164077A (en) | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
MY130271A (en) * | 1999-05-14 | 2007-06-29 | Pharma Mar Sa | Hemisynthetic method and new compounds |
CA2397597A1 (en) * | 2000-01-19 | 2001-07-26 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
US7919493B2 (en) * | 2000-04-12 | 2011-04-05 | Pharma Mar, S.A. | Anititumoral ecteinascidin derivatives |
MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
US6809099B2 (en) | 2000-11-03 | 2004-10-26 | President And Fellows Of Harvard College | Saframycins, analogues and uses thereof |
CZ20031327A3 (cs) * | 2000-11-06 | 2003-11-12 | Pharma Mar, S. A. | Užití ET-743 k výrobě léků pro účinnou protinádorovou léčbu |
GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
GB0312407D0 (en) * | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
GB0324201D0 (en) * | 2003-10-15 | 2003-11-19 | Pharma Mar Sau | Improved antitumoral combinations |
CA2544320A1 (en) * | 2003-11-13 | 2005-06-02 | Pharma Mar, S.A.U. | Method of treating cancer using a combination comprising et-743 and 5-fluorouracil |
CN1897949A (zh) * | 2003-11-14 | 2007-01-17 | 马尔药品公司 | 包含使用et-743和紫杉醇来治疗癌症的联合疗法 |
GB0326486D0 (en) * | 2003-11-14 | 2003-12-17 | Pharma Mar Sau | Combination treatment |
WO2006005602A2 (en) * | 2004-07-09 | 2006-01-19 | Pharma Mar, S.A. | Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 |
CN101068596A (zh) * | 2004-09-29 | 2007-11-07 | 法马马私人股份有限公司 | 艾可特耐思地作抗炎药 |
SI1827500T1 (sl) * | 2004-10-26 | 2009-10-31 | Pharma Mar Sa | Pegiliran liposomski doksorubicin v kombinaciji s ekteinescidinom 743 |
SI1658848T1 (sl) | 2004-10-29 | 2007-12-31 | Pharma Mar Sa | Formulacije vsebujoäśe ekteinascidin in disaharid |
GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
CN100355775C (zh) * | 2006-01-20 | 2007-12-19 | 南方医科大学 | 一种海鞘多肽及其制备方法 |
AU2008313634A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Prognostic molecular markers for ET-743 treatment |
RS54648B1 (en) | 2010-11-12 | 2016-08-31 | Pharma Mar S.A. | COMBINED THERAPY WITH ANTITUMOR ALKALOID |
AU2017215603A1 (en) * | 2016-02-04 | 2018-08-09 | Jiangsu Hengrui Medicine Co., Ltd. | Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089273A (en) * | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
US5256663A (en) * | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
US5149804A (en) * | 1990-11-30 | 1992-09-22 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 736 and 722 |
US5440055A (en) * | 1993-03-12 | 1995-08-08 | Aphios Corporation | Method and apparatus for extracting taxol from source materials |
US5478932A (en) * | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
US5721362A (en) * | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
-
1999
- 1999-04-05 US US09/286,242 patent/US6124293A/en not_active Expired - Fee Related
- 1999-04-05 EP EP99916379A patent/EP1067933B1/en not_active Expired - Lifetime
- 1999-04-05 PL PL343439A patent/PL196809B1/pl not_active IP Right Cessation
- 1999-04-05 IL IL13885699A patent/IL138856A0/xx active IP Right Grant
- 1999-04-05 DK DK99916379T patent/DK1067933T3/da active
- 1999-04-05 EP EP07011035A patent/EP1876180A3/en not_active Withdrawn
- 1999-04-05 BR BRPI9909488-6A patent/BR9909488B1/pt not_active IP Right Cessation
- 1999-04-05 PT PT99916379T patent/PT1067933E/pt unknown
- 1999-04-05 NZ NZ507350A patent/NZ507350A/xx unknown
- 1999-04-05 TR TR2000/02921T patent/TR200002921T2/xx unknown
- 1999-04-05 KR KR1020007011112A patent/KR100603219B1/ko not_active IP Right Cessation
- 1999-04-05 RU RU2000128058/04A patent/RU2217432C2/ru not_active IP Right Cessation
- 1999-04-05 MX MXPA00009840A patent/MXPA00009840A/es active IP Right Grant
- 1999-04-05 HU HU0104273A patent/HUP0104273A3/hu unknown
- 1999-04-05 CN CNB998070769A patent/CN1157189C/zh not_active Expired - Fee Related
- 1999-04-05 JP JP2000542009A patent/JP4443043B2/ja not_active Expired - Fee Related
- 1999-04-05 AT AT99916379T patent/ATE370148T1/de not_active IP Right Cessation
- 1999-04-05 DE DE69936845T patent/DE69936845T2/de not_active Expired - Lifetime
- 1999-04-05 CA CA002327468A patent/CA2327468C/en not_active Expired - Fee Related
- 1999-04-05 AU AU34713/99A patent/AU758100B2/en not_active Ceased
- 1999-04-05 WO PCT/US1999/007471 patent/WO1999051238A1/en active IP Right Grant
- 1999-04-05 CZ CZ20003650A patent/CZ301083B6/cs not_active IP Right Cessation
- 1999-04-05 SK SK1501-2000A patent/SK285669B6/sk not_active IP Right Cessation
- 1999-04-05 ES ES99916379T patent/ES2292237T3/es not_active Expired - Lifetime
- 1999-05-04 UA UA2000105674A patent/UA59439C2/uk unknown
-
2000
- 2000-10-03 NO NO20004978A patent/NO328147B1/no not_active IP Right Cessation
- 2000-10-04 IL IL138856A patent/IL138856A/en not_active IP Right Cessation
- 2000-11-02 BG BG104902A patent/BG65088B1/bg unknown
-
2001
- 2001-06-19 HK HK01104227A patent/HK1033651A1/xx not_active IP Right Cessation
-
2007
- 2007-11-08 CY CY20071101439T patent/CY1106988T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK285669B6 (sk) | Ekteinascidínová zlúčenina, farmaceutický prostriedok s jej obsahom a jej použitie | |
JP2010540471A (ja) | ガンボギン酸グリコシド誘導体及びアナログ、並びにその製法及び応用 | |
CA2457056C (en) | Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor | |
EP2824108B1 (en) | Tetracyclic anthraquinone derivatives | |
JPH10506410A (ja) | 抗腫瘍剤及び抗ウイルス剤としてのビス−(2−ハロエチル)アミノフェニル置換ジスタマイシン誘導体 | |
US20020173468A1 (en) | Modified cytostatic agents | |
HU217630B (hu) | 3'-Aziridino-antraciklin-származékok, eljárás ezek előállítására és e vegyületeket tartalmazó gyógyászati készítmények | |
ES2339152T3 (es) | Dimeros halogenados de quindolina para el tratamiento del cancer. | |
JPH05247001A (ja) | 置換ベンゾイルウレア誘導体又はその塩、それらの製造方法及びそれらを含有する抗癌剤 | |
FI61187B (fi) | Foerfarande foer framstaellning av antitumoera 1,2-5,6-dianhydro-3,4-di-0-acylgalaktitolderivat | |
KR102162351B1 (ko) | 약물-결합 화합물 및 이의 용도 | |
KR100390767B1 (ko) | 아지리디닐퀴놀린디온 유도체와 그의 제조방법 | |
CN115887687A (zh) | 一种透明质酸(ha)-ca-4偶联物及其合成方法和应用 | |
KR20180015266A (ko) | 스테로이드성 락탐 및 비스(2-클로로에틸)아미노페녹시 프로피온산 유도체의 에스테르 | |
HU206087B (en) | Process for producing n-acylated derivatives of 9,10-anthracene-dicarboxaldehyde-bis(2-imidazolin-2-yl-hydrazole) and pharmaceutical compositions comprising same as active ingredient | |
JPH0834788A (ja) | ピロロベンゾカルバゾール誘導体及びその製造方法 | |
GB2287463A (en) | Bis-anthracycline derivatives | |
JPH08151379A (ja) | ビス(ピロロインドール)誘導体及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20110405 |